NDC 71288-803-20 - Mycophenolate Mofetil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71288-803
- Requested NDC
- 71288-803-20
- Package NDCs from labels
- 71288-803-91, 71288-803-92, 71288-803-20, 71288-803-21
- Manufacturer
- Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., Ltd.
- Effective date
- 2026-08-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mycophenolate Mofetil | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., Ltd. | 2026-08-04 | HUMAN PRESCRIPTION DRUG LABEL |
| Mycophenolate Mofetil | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., Ltd. | 2026-04-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71288-803-20 | Mycophenolate Mofetil | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 20 | 15 | |
| 71288-803-21 | Mycophenolate Mofetil | 4 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 4 | 15 | |
| 71288-803-91 | Mycophenolate Mofetil | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 20 | 1 | |
| 71288-803-92 | Mycophenolate Mofetil | 4 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 4 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71288-803 | MYCOPHENOLATE MOFETIL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MEITHEAL PHARMACEUTICALS INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20230908_9650af9b-d36f-4a2f-9647-d0f798933402.zip |
| 71288-803 | MYCOPHENOLATE MOFETIL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MEITHEAL PHARMACEUTICALS INC.] | 1 | Current NDC, Legacy NDC, 2 package rows | 20240317_b41cca9f-0922-4171-8d1b-8e0d32ae1cc1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71288-803-20 | EA - Each | 71288-803 | ee249c0a-5862-42a3-99f9-78e85b7f73cc | 1 | 2021-04-08 |
| 71288-803-21 | EA - Each | 71288-803 | 4083248a-a629-4bae-80e8-1f31c7cacc43 | 1 | 2021-04-08 |
| 71288-803-91 | EA - Each | 71288-803 | 0269d0ae-d3f5-4bd5-8990-be6c25455638 | 1 | 2024-04-05 |
| 71288-803-92 | EA - Each | 71288-803 | 22ff0dc9-db07-4d2c-b833-e30d6a911658 | 1 | 2024-04-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mycophenolate mofetil | MYCOPHENOLATE MOFETIL | REMEDYREPACK INC. | 84c6f6bb-8924-4da5-9629-126197195f83 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 9242ECW6R0 |
| Mycophenolate mofetil | MYCOPHENOLATE MOFETIL | Strides Pharma Inc. | 9d8c09fc-1df2-4f39-8e1a-c4b296d1a260 | 2026-09-07 | Boxed warning, Warnings, Adverse reactions | 9242ECW6R0 |
| 450771d2-0c98-4eef-bf1c-65702b4dde75 | b41cca9f-0922-4171-8d1b-8e0d32ae1cc1 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | b41cca9f-0922-4171-8d1b-8e0d32ae1cc1 | ||
| Mycophenolate Mofetil | MYCOPHENOLATE MOFETIL | Teva Pharmaceuticals USA, Inc. | b414303f-e6f3-4e22-a537-96be352b59a4 | 2026-08-31 | Boxed warning, Warnings, Adverse reactions | 9242ECW6R0 |
| mycophenolate mofetil | MYCOPHENOLATE MOFETIL | AvPAK | fbbe6521-0e21-5372-e053-6394a90ae5e4 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 9242ECW6R0 |
| Rohto Max Strength | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | e4b49550-1ca3-4bd7-854d-409b53fa5e26 | 2026-08-20 | Warnings | 6OZP39ZG8H |
| Adaptopath | ADENOSINUM CYCLOPHOSPHORICUM, ALPHA-LIPOICUM ACIDUM, ARGENTUM METALLICUM, AVENA SATIVA, CAPSICUM ANNUUM, CITRICUM ACIDUM, COENZYME A, CUPRUM METALLICUM, GINKGO BILOBA, GLANDULA SUPRARENALIS SUIS, GLYCYRRHIZA GLABRA, HYPOTHALAMUS (BOVINE), IODIUM, LEDUM PALUSTRE, MANGANUM ACETICUM, NADIDUM, NATRUM CARBONICUM, OLEUM MORRHUAE, PHOSPHORICUM ACIDUM, PICRICUM ACIDUM, RIBOFLAVINUM, SELENIUM METALLICUM SEPIA, SILICEA, THIAMINUM HYDROCHLORICUM, THYROIDINUM (BOVINE), VANADIUM METALLICUM | Energetix Corporation | 41234598-0cb5-41c2-bfbe-1c15ee9bf502 | 2026-08-11 | Warnings | XF417D3PSL |
| Aller-Chord A | ALFALFA, ALLIUM CEPA, AMBROSIA ARTEMISIAEFOLIA, BRYONIA (ALBA), CITRICUM ACIDUM, COUMARINUM, EUPHRASIA OFFICINALIS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, JUNIPERUS COMMUNIS, MUCOSA NASALIS SUIS, NATRUM SULPHURICUM, PHOSPHORUS, POTHOS FOETIDUS, PULSATILLA (VULGARIS), SOLIDAGO VIRGAUREA, SULPHUR, TANACETUM VULGARE, TARAXACUM OFFICINALE, TRIFOLIUM PRATENSE | Energetix Corporation | 09e89c92-112d-4320-9df5-b9f938bb9095 | 2026-08-11 | Warnings | XF417D3PSL |
| Hepatic-Tone | CARDUUS MARIANUS, CEANOTHUS AMERICANUS, CHELIDONIUM MAJUS, CHIONANTHUS VIRGINICA, CITRICUM ACIDUM, CYSTEINUM, HEPAR SUIS, LEPTANDRA VIRGINICA, MAGNESIA MURIATICA, NATRUM SULPHURICUM, NUX VOMICA, PHOSPHORUS, QUASSIA (AMARA), TARAXACUM OFFICINALE | Energetix Corporation | d5f61f13-7e9f-4e46-8ad8-0336f36288df | 2026-08-11 | Warnings | XF417D3PSL |
| Isopathic Phenolic Rings | HOMEOPATHIC LIQUID | Energetix Corporation | 98a7ca26-ccb7-43c7-bd65-892fcbacc882 | 2026-08-11 | Warnings | XF417D3PSL |
| Metabopath | ADENOSINUM CYCLOPHOSPHORICUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, BERBERIS VULGARIS, CITRICUM ACIDUM, COENZYME A, DNA, FUMARICUM ACIDUM, GLYCYRRHIZA GLABRA, HEPAR SULPHURIS CALCAREUM, LAPPA MAJOR, MAGNESIA PHOSPHORICA, MANGANUM ACETICUM, NADIDUM, NATRUM MURIATICUM, NATRUM OXALACETICUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PULSATILLA, PYRIDOXINUM HYDROCHLORICUM, RHAMNUS PURSHIANA, RIBOFLAVINUM, RNA, SILICEA, SUCCINICUM ACIDUM, SULPHUR, THIAMINUM HYDROCHLORICUM, | Energetix Corporation | 58bfe670-d308-45a2-8046-7897b6221452 | 2026-08-11 | Warnings | XF417D3PSL |
| Mycophenolate Mofetil | MYCOPHENOLATE MOFETIL | Amneal Pharmaceuticals LLC | 27fd9381-8d82-4187-897f-98f41f94e90f | 2026-08-10 | Boxed warning, Warnings, Adverse reactions | 9242ECW6R0 |
| Mycophenolate Mofetil | MYCOPHENOLATE MOFETIL | A-S Medication Solutions | b4170ad9-67f0-42ea-b694-6b80824a607a | 2026-08-10 | Boxed warning, Warnings, Adverse reactions | 9242ECW6R0 |
| Mycophenolate Mofetil | MYCOPHENOLATE MOFETIL | QUAGEN PHARMACEUTICALS LLC | 838449b3-4397-4e35-b9b9-683f5a48bff2 | 2026-08-06 | Boxed warning, Warnings, Adverse reactions | 9242ECW6R0 |
| CellCept | MYCOPHENOLATE MOFETIL | Genentech, Inc. | 37241e87-4af4-4dc3-a1aa-ea6f20d8dc40 | 2026-08-05 | Boxed warning, Warnings, Adverse reactions | 311881 9242ECW6R0 |
| Droptics Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80 | Droptics LLC | 29d7614b-f4b7-48e2-97c5-d1bff27731d2 | 2026-07-22 | Warnings | 6OZP39ZG8H |
| Xenleta | LEFAMULIN ACETATE | Meitheal Pharmaceuticals Inc. | eb972ea8-7502-422e-84bb-66cb8e93ca06 | 2026-07-22 | Warnings, Adverse reactions | XF417D3PSL |
| mycophenolate mofetil | MYCOPHENOLATE MOFETIL | Major Pharmaceuticals | 6abc5727-ee8e-43ad-ab39-0eef2feb257a | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 9242ECW6R0 |
| Rohto Cool Relief | NAPHAZOLINE HYDROCHLORIDE, POLYSORBATE 80 | The Mentholatum Company | dc8f1ff3-87ae-47ca-815f-5a0e34f8cf30 | 2026-06-19 | Warnings | 6OZP39ZG8H |
| E-Z-GAS II | ANTACID/ANTIFLATULENT | E-Z-EM, INC. | 4e12e1cb-b033-076d-e054-00144ff8d46c | 2026-06-15 | Warnings | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.